Surmodics reported $62.18M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Align Technology ALGN:US $ 1086.36M 45.34M
Anika Therapeutics ANIK:US $ 97.18M 2.58M
Arrowhead Research ARWR:US $ 325.98M 46.4M
Baxter International BAX:US $ 3136M 46M
Bioscrip BIOS:US $ 157.53M 48.16M
Cryolife CRY:US $ 50.47M 6.08M
Edap Tms EDAP:US $ 44.96M 20.58M
Edwards Lifesciences EW:US $ 1312.8M 138.6M
Genmark Diagnostics GNMK:US $ 40.57M 17.24M
Haemonetics HAE:US $ 173.46M 18.84M
Heron Therapeutics HRTX:US $ 191.17M 131.43M
Merit Medical Systems MMSI:US $ 69.67M 11.15M
Mesa Laboratories MLAB:US $ 275.71M 11.84M
Nektar Therapeutics NKTR:US $ 152.34M 2.18M
Oxford Immunotec Global OXFD:US $ 160.62M 4.87M
Providence Service PRSC:US $ 290.91M 8.65M
Stryker SYK:US $ 2241M 3M
Surmodics SRDX:US $ 62.18M 14.02M
Trinity Biotech TRIB:US $ 28.62M 3.66M